Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gottfried Novacek

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Gastroenterology|April 23, 2015
A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel diseaseWalter Reinisch, Istvan Altorjay, Ferenc Zsigmond, et al.
AJR. American Journal of Roentgenology|August 20, 2002
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CTWolfgang Schima, Reinhold Függer, Ewald Schober, et al.
Inflammatory Bowel Diseases|March 9, 2007
Complications in Crohn's disease: right-sided ureteric stenosis and hydronephrosisSieglinde Angelberger, Klaus G Fink, Wolfgang Schima, et al.
Journal of Crohn'S & Colitis|December 3, 2013
Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's diseaseWerner Schmid, Harald Vogelsang, Pavol Papay, et al.
Vaccines|May 28, 2022
Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel DiseasesJagoda Pokryszka, Angelika Wagner, Ursula Wiedermann, et al.
Zeitschrift Fur Gastroenterologie|August 14, 2018
[Ustekinumab - Current position]Britta Siegmund, Christoph Högenauer, Gottfried Novacek, et al.
Journal of Clinical Medicine|September 23, 2022
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective StudyMaximilian Kutschera, Valentin Ritschl, Berthold Reichardt, et al.
Inflammatory Bowel Diseases|February 26, 2011
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurinesAndrea Walch, Miena Meshkat, Harald Vogelsang, et al.
Inflammatory Bowel Diseases|June 13, 2020
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's DiseaseSusanna Scharrer, Donata Lissner, Christian Primas, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Gastroenterology|April 23, 2015
A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel diseaseWalter Reinisch, Istvan Altorjay, Ferenc Zsigmond, et al.
AJR. American Journal of Roentgenology|August 20, 2002
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CTWolfgang Schima, Reinhold Függer, Ewald Schober, et al.
Inflammatory Bowel Diseases|March 9, 2007
Complications in Crohn's disease: right-sided ureteric stenosis and hydronephrosisSieglinde Angelberger, Klaus G Fink, Wolfgang Schima, et al.
Journal of Crohn'S & Colitis|December 3, 2013
Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's diseaseWerner Schmid, Harald Vogelsang, Pavol Papay, et al.
Vaccines|May 28, 2022
Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel DiseasesJagoda Pokryszka, Angelika Wagner, Ursula Wiedermann, et al.
Zeitschrift Fur Gastroenterologie|August 14, 2018
[Ustekinumab - Current position]Britta Siegmund, Christoph Högenauer, Gottfried Novacek, et al.
Journal of Clinical Medicine|September 23, 2022
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective StudyMaximilian Kutschera, Valentin Ritschl, Berthold Reichardt, et al.
Inflammatory Bowel Diseases|February 26, 2011
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurinesAndrea Walch, Miena Meshkat, Harald Vogelsang, et al.
Inflammatory Bowel Diseases|June 13, 2020
Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's DiseaseSusanna Scharrer, Donata Lissner, Christian Primas, et al.
Pageof 7